Cargando…
Impact of quality of response on survival outcomes among multiple myeloma patients treated with novel agents – a retrospective analysis
BACKGROUND: In this era of target therapies, novel data on the correlation between response endpoints and survival outcomes in multiple myeloma have arisen. OBJECTIVE: To determine the impact of quality of response on clinical outcomes, using first-line treatment, and identify risk factors influenci...
Autores principales: | Ćojbašić, Irena, Vučić, Miodrag, Tijanić, Ivan, Ćojbašić, Žarko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Paulista de Medicina - APM
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610252/ https://www.ncbi.nlm.nih.gov/pubmed/35195237 http://dx.doi.org/10.1590/1516-3180.2021.0174.R2.22062021 |
Ejemplares similares
-
Clinical Outcomes of Patients with Chronic Myeloid Leukemia and COVID-19 Infection—A Single Center Survey
por: Ćojbašić, Irena, et al.
Publicado: (2023) -
Intelligent Flow Friction Estimation
por: Brkić, Dejan, et al.
Publicado: (2016) -
Effects of 6-months of oral ferrous and ferric supplement therapy in patients who were hospitalized for decompensated chronic heart failure
por: Zdravkovic, Snezana Ciric, et al.
Publicado: (2019) -
Review of health-related quality of life data in multiple myeloma patients treated with novel agents
por: Sonneveld, P, et al.
Publicado: (2013) -
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma
por: Puertas, Borja, et al.
Publicado: (2023)